1704P Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study.
Saved in:
| Title: | 1704P Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study. |
|---|---|
| Authors: | Saliby, R.M.1 (AUTHOR), Xie, W.2 (AUTHOR), Wells, J.C.3 (AUTHOR), Saad, E.1 (AUTHOR), Eid, M.1 (AUTHOR), Semaan, K.1 (AUTHOR), Labaki, C.4 (AUTHOR), Ferrier, E.5 (AUTHOR), Zarba, M.5 (AUTHOR), Ebrahimi, H.6 (AUTHOR), Suarez Rodriguez, C.7 (AUTHOR), Ruiz, J.M.8 (AUTHOR), Powles, T.B.9 (AUTHOR), Wood, L.A.10 (AUTHOR), De Velasco Oria, G.A.11 (AUTHOR), Takemura, K.12 (AUTHOR), Braun, D.A.13 (AUTHOR), Heng, D.Y.C.14 (AUTHOR), Choueiri, T.K.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1021-S1022. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179693145 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1704P Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Saliby%2C+R%2EM%2E%22">Saliby, R.M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+W%2E%22">Xie, W.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wells%2C+J%2EC%2E%22">Wells, J.C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saad%2C+E%2E%22">Saad, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eid%2C+M%2E%22">Eid, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Semaan%2C+K%2E%22">Semaan, K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Labaki%2C+C%2E%22">Labaki, C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ferrier%2C+E%2E%22">Ferrier, E.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zarba%2C+M%2E%22">Zarba, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ebrahimi%2C+H%2E%22">Ebrahimi, H.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Suarez+Rodriguez%2C+C%2E%22">Suarez Rodriguez, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruiz%2C+J%2EM%2E%22">Ruiz, J.M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powles%2C+T%2EB%2E%22">Powles, T.B.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wood%2C+L%2EA%2E%22">Wood, L.A.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Velasco+Oria%2C+G%2EA%2E%22">De Velasco Oria, G.A.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Takemura%2C+K%2E%22">Takemura, K.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braun%2C+D%2EA%2E%22">Braun, D.A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heng%2C+D%2EY%2EC%2E%22">Heng, D.Y.C.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choueiri%2C+T%2EK%2E%22">Choueiri, T.K.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS1021-S1022. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179693145 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.1797 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1021 Titles: – TitleFull: 1704P Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Saliby, R.M. – PersonEntity: Name: NameFull: Xie, W. – PersonEntity: Name: NameFull: Wells, J.C. – PersonEntity: Name: NameFull: Saad, E. – PersonEntity: Name: NameFull: Eid, M. – PersonEntity: Name: NameFull: Semaan, K. – PersonEntity: Name: NameFull: Labaki, C. – PersonEntity: Name: NameFull: Ferrier, E. – PersonEntity: Name: NameFull: Zarba, M. – PersonEntity: Name: NameFull: Ebrahimi, H. – PersonEntity: Name: NameFull: Suarez Rodriguez, C. – PersonEntity: Name: NameFull: Ruiz, J.M. – PersonEntity: Name: NameFull: Powles, T.B. – PersonEntity: Name: NameFull: Wood, L.A. – PersonEntity: Name: NameFull: De Velasco Oria, G.A. – PersonEntity: Name: NameFull: Takemura, K. – PersonEntity: Name: NameFull: Braun, D.A. – PersonEntity: Name: NameFull: Heng, D.Y.C. – PersonEntity: Name: NameFull: Choueiri, T.K. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
